VPS41 and Parkinson disease: Previously, a screen for neuroprotective factors in a transgenic C. elegans model for Parkinson’s disease showed that overexpression of human VPS41 protects against α‐synuclein‐induced neurodegeneration (Hamamichi etal, 2008; Ruan etal, 2010; Harrington etal, 2012).